Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia

INTRODUCTION: Insulin degludec (degludec) has proven benefits in type 2 diabetes (T2D), in terms of improved glycaemic control, low risk of hypoglycaemia, and flexibility in dosing time. This prospective non-interventional UPDATES study aimed to investigate whether results obtained from randomised c...

Descripción completa

Detalles Bibliográficos
Autores principales: AlMalki, Mussa H., Aldesokey, Hossam, Alkhafaji, Dania, Alsheikh, Abdulrahman, Braae, Uffe Christian, Lehrskov, Lars Lang, Magawry, Waleed, Yahia, Moataz, Haroun, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685061/
https://www.ncbi.nlm.nih.gov/pubmed/36417058
http://dx.doi.org/10.1007/s12325-022-02366-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685061/
https://www.ncbi.nlm.nih.gov/pubmed/36417058
http://dx.doi.org/10.1007/s12325-022-02366-0

Ejemplares similares